Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
16 2월 2024 - 3:15AM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (TSX:CRDL)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Cardiol Therapeutics (TSX:CRDL)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024